Skip to main navigation
  • Investors & Media
    • Newsroom
    • Events
    • Stock Information
    • Financials
    • Governance
    • Investor Resources
  • Medical Professionals
  • Careers
    • Apply to Ionis
    • Intern Program
    • Postdoctoral Program
  • Contact Us
Ionis Pharmaceuticals, Inc. home page

Main navigation

  • About Us
    • Our Leadership
    • DE&I
    • Corporate Responsibility
    • Grants & Sponsorships
  • Areas of Focus
  • Science & Innovation
    • Pipeline
    • Clinical Trials
    • Ion-ARPA Initiative
  • Medicines
  • Patients & Advocacy
    • Patient Stories
    • Patient Resources
    • Expanded Access Policy
Media Center

Investor Relations

  • Overview
  • Newsroom
    • Press Releases
    • Company Statements
    • InBriefs
    • Media Center
  • Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
    • Ownership Profile
  • Financials
    • SEC Filings
    • Annual Reports
  • Governance
    • Governance Documents
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Settlement Information
    • Contact Us
  • Investor Email Alerts

Investor contact

760-603-2331

Email

Media contact

760-603-4679

Email

Annual Reports

2023 Annual Report
2023 Annual Report

Previous Years

2022 Annual Report
2022 Annual Report
2021 Annual Report
2021 Annual Report
2020 Annual Report
2020 Annual Report

Footer Navigation

  • Information For:
    • Medical Professionals
    • Investors & Media
    • Job Seekers
    • Suppliers
  • Legal and Compliance:
    • Legal Notice
    • Code of Ethics and Business Conduct
    • Privacy Policy
    • Limit the Use of My Sensitive Personal Information
    • Akcea Therapeutics
  • Explore:
    • Our Story
    • Our Science
    • Our Pipeline
    • Our Culture
    • Our News
  • Stay Connected:
    • Contact Us
    • LinkedIn
    • X
    • Instagram
    • Facebook
    • Community Guidelines

©1989 – 2024 Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc.
Akcea Therapeutics® is a wholly owned subsidiary of Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. logo